BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 17113254)

  • 1. Mechanisms of cisplatin-induced ototoxicity and prevention.
    Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
    Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
    Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity: therapeutic opportunities.
    Rybak LP; Whitworth CA
    Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
    Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
    Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
    Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
    Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
    Lynch ED; Gu R; Pierce C; Kil J
    Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
    Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
    J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
    Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal bone histopathology of cisplatin ototoxicity.
    Hinojosa R; Riggs LC; Strauss M; Matz GJ
    Am J Otol; 1995 Nov; 16(6):731-40. PubMed ID: 8572135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity.
    Rybak LP; Ramkumar V
    Kidney Int; 2007 Oct; 72(8):931-5. PubMed ID: 17653135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ; Tang H
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract]   [Full Text] [Related]  

  • 13. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
    Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
    Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against cisplatin ototoxicity.
    Yassuda CC; Righetti AE; Cury MC; Hyppolito MA; Oliveira JA; Féres O
    Acta Cir Bras; 2008; 23 Suppl 1():72-6; discussion 76. PubMed ID: 18516452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea.
    Alam SA; Ikeda K; Oshima T; Suzuki M; Kawase T; Kikuchi T; Takasaka T
    Hear Res; 2000 Mar; 141(1-2):28-38. PubMed ID: 10713493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
    Li G; Liu W; Frenz D
    Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.